Q9EQU3 (TLR9_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 112.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Toll-like receptor 9 Alternative name(s): CD_antigen=CD289 | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 1032 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Key component of innate and adaptive immunity. TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. TLR9 is a nucleotide-sensing TLR which is activated by unmethylated cytidine-phosphate-guanosine (CpG) dinucleotides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Plays a role in defense against systemic mouse cytomegalovirus infection. Controls lymphocyte response to Helicobacter infection. Ref.5 Ref.6 |
| Subunit structure | Interacts with MYD88 via their respective TIR domains By similarity. Interacts with BTK By similarity. Interacts (via transmembrane domain) with UNC93B1. Interacts with CD300LH; the interaction may promote full activation of TLR9-triggered innate responses. Interacts with CNPY3 and HSP90B1; this interaction is required for proper folding in the endoplasmic reticulum. Ref.7 Ref.8 Ref.10 Ref.12 |
| Subcellular location | Endoplasmic reticulum membrane; Single-pass type I membrane protein. Endosome. Lysosome. Cytoplasmic vesicle › phagosome. Note: Relocalizes from endoplasmic reticulum to endosome and lysosome upon stimulation with agonist. Ref.9 |
| Tissue specificity | Expressed in the basolateral region of gastric epithelial cells with high levels detected in antrum and body mucosa (at protein level). Detected in spleen and stomach at higher levels in C57BL/6 mice than BALB/C. Ref.5 |
| Induction | Following Helicobacter infection, down-regulated in C57BL/6 mice and up-regulated in BALB/C mice. Ref.5 |
| Disruption phenotype | Reduced proliferation of lymphocytes, reduced interferon-gamma production by splenocytes and reduced neutrophil numbers following Helicobacter infection. Ref.5 |
| Sequence similarities | Belongs to the Toll-like receptor family. Contains 26 LRR (leucine-rich) repeats. Contains 1 TIR domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 25 | 25 | Potential | ||||||
| Chain | 26 – 1032 | 1007 | Toll-like receptor 9 | PRO_0000034738 | |||||
Regions | |||||||||
| Topological domain | 26 – 818 | 793 | Extracellular Potential | ||||||
| Transmembrane | 819 – 839 | 21 | Helical; Potential | ||||||
| Topological domain | 840 – 1032 | 193 | Cytoplasmic Potential | ||||||
| Repeat | 62 – 85 | 24 | LRR 1 | ||||||
| Repeat | 87 – 110 | 24 | LRR 2 | ||||||
| Repeat | 122 – 147 | 26 | LRR 3 | ||||||
| Repeat | 150 – 166 | 17 | LRR 4 | ||||||
| Repeat | 167 – 190 | 24 | LRR 5 | ||||||
| Repeat | 198 – 221 | 24 | LRR 6 | ||||||
| Repeat | 223 – 242 | 20 | LRR 7 | ||||||
| Repeat | 243 – 268 | 26 | LRR 8 | ||||||
| Repeat | 283 – 306 | 24 | LRR 9 | ||||||
| Repeat | 308 – 332 | 25 | LRR 10 | ||||||
| Repeat | 333 – 356 | 24 | LRR 11 | ||||||
| Repeat | 363 – 386 | 24 | LRR 12 | ||||||
| Repeat | 390 – 413 | 24 | LRR 13 | ||||||
| Repeat | 415 – 440 | 26 | LRR 14 | ||||||
| Repeat | 471 – 495 | 25 | LRR 15 | ||||||
| Repeat | 497 – 520 | 24 | LRR 16 | ||||||
| Repeat | 521 – 544 | 24 | LRR 17 | ||||||
| Repeat | 546 – 573 | 28 | LRR 18 | ||||||
| Repeat | 575 – 599 | 25 | LRR 19 | ||||||
| Repeat | 601 – 623 | 23 | LRR 20 | ||||||
| Repeat | 628 – 651 | 24 | LRR 21 | ||||||
| Repeat | 653 – 676 | 24 | LRR 22 | ||||||
| Repeat | 677 – 700 | 24 | LRR 23 | ||||||
| Repeat | 702 – 724 | 23 | LRR 24 | ||||||
| Repeat | 725 – 748 | 24 | LRR 25 | ||||||
| Repeat | 750 – 773 | 24 | LRR 26 | ||||||
| Domain | 868 – 1016 | 149 | TIR | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 64 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 129 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 147 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 200 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 210 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 242 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 300 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 309 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 332 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 340 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 495 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 514 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 568 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 670 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 695 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 700 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 732 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 752 | 1 | N-linked (GlcNAc...) Potential | ||||||
Experimental info | |||||||||
| Mutagenesis | 499 | 1 | L → P: Highly susceptible to mouse cytomegalovirus infection. Shows low level of cytokine induction and natural killer activation on viral infection. Ref.6 | ||||||
| Sequence conflict | 325 | 1 | T → N in BAB19260. Ref.1 | ||||||
| Sequence conflict | 325 | 1 | T → N in AAK29625. Ref.2 | ||||||
| Sequence conflict | 325 | 1 | T → N in AAK28488. Ref.3 | ||||||
| Sequence conflict | 325 | 1 | T → N in AAU04980. Ref.5 | ||||||
| Sequence conflict | 378 | 1 | L → S in BAB19260. Ref.1 | ||||||
| Sequence conflict | 378 | 1 | L → S in AAK29625. Ref.2 | ||||||
| Sequence conflict | 378 | 1 | L → S in AAK28488. Ref.3 | ||||||
| Sequence conflict | 378 | 1 | L → S in AAU04980. Ref.5 | ||||||
| Sequence conflict | 554 | 1 | S → G in AAK28488. Ref.3 | ||||||
| Sequence conflict | 562 | 1 | M → I in AAK28488. Ref.3 | ||||||
| Sequence conflict | 573 | 1 | T → A in AAK29625. Ref.2 | ||||||
| Sequence conflict | 573 | 1 | T → A in AAK28488. Ref.3 | ||||||
| Sequence conflict | 573 | 1 | T → A in AAU04980. Ref.5 | ||||||
| Sequence conflict | 579 | 1 | Q → H in AAK29625. Ref.2 | ||||||
| Sequence conflict | 579 | 1 | Q → H in AAK28488. Ref.3 | ||||||
| Sequence conflict | 579 | 1 | Q → H in AAU04980. Ref.5 | ||||||
| Sequence conflict | 867 | 1 | T → A in AAK29625. Ref.2 | ||||||
| Sequence conflict | 867 | 1 | T → A in AAK28488. Ref.3 | ||||||
| Sequence conflict | 867 | 1 | T → A in AAU04980. Ref.5 | ||||||
| Sequence conflict | 897 | 1 | E → G in AAK28488. Ref.3 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A Toll-like receptor recognizes bacterial DNA." Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. Nature 408:740-745(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition." Bauer S.M., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., Wagner H., Lipford G.B. Proc. Natl. Acad. Sci. U.S.A. 98:9237-9242(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Macrophage. |
| [3] | "Toll-like receptor 9 mediates CpG-DNA signaling." Chuang T.-H., Lee J., Kline L., Mathison J.C., Ulevitch R.J. J. Leukoc. Biol. 71:538-544(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Strain: BALB/c. |
| [4] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [5] | "TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: results from a genome-wide scan." Anderson A.E., Worku M.L., Khamri W., Bamford K.B., Walker M.M., Thursz M.R. Eur. J. Immunol. 37:1548-1561(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-964, FUNCTION, TISSUE SPECIFICITY, INDUCTION, DISRUPTION PHENOTYPE. Strain: BALB/c and C57BL/6. |
| [6] | "Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection." Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., Mudd S., Shamel L., Sovath S., Goode J., Alexopoulou L., Flavell R.A., Beutler B. Proc. Natl. Acad. Sci. U.S.A. 101:3516-3521(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN CYTOMEGALOVIRUS INFECTION, MUTAGENESIS OF LEU-499. |
| [7] | "The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling." Brinkmann M.M., Spooner E., Hoebe K., Beutler B., Ploegh H.L., Kim Y.M. J. Cell Biol. 177:265-275(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH UNC93B1. |
| [8] | "A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors." Kiyokawa T., Akashi-Takamura S., Shibata T., Matsumoto F., Nishitani C., Kuroki Y., Seto Y., Miyake K. Int. Immunol. 20:1407-1415(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CNPY3. |
| [9] | "UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes." Kim Y.M., Brinkmann M.M., Paquet M.E., Ploegh H.L. Nature 452:234-238(2008) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [10] | "Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone." Liu B., Yang Y., Qiu Z., Staron M., Hong F., Li Y., Wu S., Li Y., Hao B., Bona R., Han D., Li Z. Nat. Commun. 1:79-79(2010) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CNPY3 AND HSP90B1. |
| [11] | Erratum Liu B., Yang Y., Qiu Z., Staron M., Hong F., Li Y., Wu S., Li Y., Hao B., Bona R., Han D., Li Z. Nat. Commun. 3:653-653(2012) |
| [12] | "CMRF-35-like molecule 3 preferentially promotes TLR9-triggered proinflammatory cytokine production in macrophages by enhancing TNF receptor-associated factor 6 ubiquitination." Wu Y., Zhu X., Li N., Chen T., Yang M., Yao M., Liu X., Jin B., Wang X., Cao X. J. Immunol. 187:4881-4889(2011) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CD300LH. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AB045181 mRNA. Translation: BAB19260.1. AF348140 mRNA. Translation: AAK29625.1. AF314224 mRNA. Translation: AAK28488.1. AC164430 Genomic DNA. No translation available. AY649790 Genomic DNA. Translation: AAU04980.1. AY649791 Genomic DNA. Translation: AAU04981.1. |
| IPI | IPI00318748. IPI01027735. |
| RefSeq | NP_112455.2. NM_031178.2. |
| UniGene | Mm.44889. |
3D structure databases | |
| ProteinModelPortal | Q9EQU3. |
| SMR | Q9EQU3. Positions 35-1013. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 10090.ENSMUSP00000082207. |
PTM databases | |
| PhosphoSite | Q9EQU3. |
Proteomic databases | |
| PaxDb | Q9EQU3. |
| PRIDE | Q9EQU3. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000062241; ENSMUSP00000082207; ENSMUSG00000045322. |
| GeneID | 81897. |
| KEGG | mmu:81897. |
Organism-specific databases | |
| CTD | 54106. |
| MGI | MGI:1932389. Tlr9. |
Phylogenomic databases | |
| eggNOG | COG4886. |
| GeneTree | ENSGT00680000099674. |
| HOGENOM | HOG000230468. |
| HOVERGEN | HBG018601. |
| InParanoid | Q4L0K3. |
| KO | K10161. |
| OMA | VGGNCRR. |
| OrthoDB | EOG47SSDD. |
Gene expression databases | |
| Bgee | Q9EQU3. |
| CleanEx | MM_TLR9. |
| Genevestigator | Q9EQU3. |
| GermOnline | ENSMUSG00000045322. Mus musculus. |
Family and domain databases | |
| InterPro | IPR001611. Leu-rich_rpt. IPR003591. Leu-rich_rpt_typical-subtyp. IPR000157. TIR_dom. IPR027181. TLR9. [Graphical view] |
| PANTHER | PTHR24373:SF37. PTHR24373:SF37. 1 hit. |
| Pfam | PF00560. LRR_1. 2 hits. PF01582. TIR. 1 hit. [Graphical view] |
| SMART | SM00369. LRR_TYP. 1 hit. [Graphical view] |
| SUPFAM | SSF52200. TIR. 1 hit. |
| PROSITE | PS51450. LRR. 16 hits. PS50104. TIR. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChEMBL | CHEMBL6128. |
| NextBio | 350461. |
| SOURCE | Search... |
Entry information
| Entry name | TLR9_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q9EQU3 Secondary accession number(s): F8VPN5 Q99MQ8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
